PF-00835231   Click here for help

GtoPdb Ligand ID: 11250

Synonyms: compound 4 [Hoffman et al., 2020] [2] | PF-0835231
PDB Ligand
Compound class: Synthetic organic
Comment: PF-00835231 was designed to inhibit the 3CL protease (Mpro) of SARS-CoV-1, and has efficacy against a range of 3CLpro from α-, β-, and γ-coronaviruses [1-2]. It is the active metabolite of the more soluble phosphate analogue lufotrelvir (PF-07304814). The pharmaceutical properties make both compounds suitable for intravenous infusion.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 8
Hydrogen bond donors 5
Rotatable bonds 13
Topological polar surface area 149.62
Molecular weight 472.23
XLogP 1.06
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OCC(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1[nH]c2c(c1)c(OC)ccc2)CC(C)C)C[C@@H]1CCNC1=O
Isomeric SMILES OCC(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1[nH]c2c(c1)c(OC)ccc2)CC(C)C)C[C@@H]1CCNC1=O
InChI InChI=1S/C24H32N4O6/c1-13(2)9-18(23(32)27-17(20(30)12-29)10-14-7-8-25-22(14)31)28-24(33)19-11-15-16(26-19)5-4-6-21(15)34-3/h4-6,11,13-14,17-18,26,29H,7-10,12H2,1-3H3,(H,25,31)(H,27,32)(H,28,33)/t14-,17-,18-/m0/s1
InChI Key QDIMHKWNHMVDJB-WBAXXEDZSA-N
Bioactivity Comments
SARS-CoV-2 3CLpro Ki = 0.27 nM; IC50 = 6.9 nM
SARS-CoV 3CLpro Ki = 4 nM [1]. PF-00835231 does not inhibit HIV and HCV proteases or a range of human proteases.
Selectivity at other protein targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
CoV 3C-like (main) protease SARS-CoV Inhibitor Inhibition 8.4 pKi - 2
pKi 8.4 (Ki 4x10-9 M) [2]
Description: Determined using an in vitro SARS-CoV-1 3CLpro FRET assay.
CoV 3C-like (main) protease SARS-CoV-2 Inhibitor Inhibition 8.1 pIC50 - 3
pIC50 8.1 (IC50 8x10-9 M) [3]